I am a
Home I AM A Search Login

Papers of the Week


Papers: 20 Aug 2022 - 26 Aug 2022


Pharmacology/Drug Development


2022 Aug 12


ACS Pharmacol Transl Sci


5


8

Characterization of Dual-Acting A Adenosine Receptor Positive Allosteric Modulators That Preferentially Enhance Adenosine-Induced Gα and Gα Isoprotein Activation.

Authors

Fisher CL, Fallot LB, Wan TC, Keyes RF, Suresh RR, Rothwell AC, Gao Z-G, McCorvy JD, Smith BC, Jacobson KA, Auchampach JA
ACS Pharmacol Transl Sci. 2022 Aug 12; 5(8):625-641.
PMID: 35983277.

Abstract

The A adenosine receptor (AAR) is a promising therapeutic target for inflammatory diseases, cancer, and chronic neuropathic pain, with agonists already in advanced clinical trials. Here we report an in-depth comparison of the pharmacological properties and structure-activity relationships of existing and expanded compound libraries of 2-substituted 1-imidazo[4,5-]quinolin-4-amine and 4-amino-substituted quinoline derivatives that function as AAR positive allosteric modulators (PAMs). We also show that our lead compound from each series enhances adenosine-induced AAR signaling preferentially toward activation of Gα and Gα isoproteins, which are coexpressed with the AAR in immune cells and spinal cord neurons. Finally, utilizing an extracellular/intracellular chimeric AAR approach composed of sequences from a responding (human) and a nonresponding (mouse) species, we provide evidence in support of the idea that the imidazoquinolin-4-amine class of PAMs variably interacts dually with the orthosteric ligand binding site as well as with a separate allosteric site located within the inner/intracellular regions of the receptor. This study has advanced both structural and pharmacological understanding of these two classes of AAR PAMs, which includes leads for future pharmaceutical development.